Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study - PubMed (original) (raw)

Clinical Trial

Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study

No authors listed. Diabetologia. 1994 Mar.

Abstract

The prevalence of microvascular and acute diabetic complications, and their relation to duration of diabetes and glycaemic control were examined in a cross-sectional study of 3250 IDDM patients in Europe (EURODIAB IDDM Complications Study). Mean (SD) duration of diabetes was 14.7 (9.3) years. HbA1c and AER were measured centrally. Retinopathy was assessed by centrally graded retinal photography. Autonomic neuropathy was measured by heart rate and blood pressure responses to standing up. Sensory neuropathy was measured by biothesiometry. Normal HbA1c was found in 16% of patients. An AER of 20 micrograms/min or higher was found in 30.6% (95% CI 29.0%, 32.2%) of all patients, and 19.3% (15.6%, 23.0%) of those with diabetes for 1 to 5 years. The prevalence of retinopathy (46% in all patients; 82% after 20 or more years) was substantially lower than in comparable studies. Of all patients 5.9% (5.1%, 6.7%) had postural hypotension, 19.3% (17.9%, 20.7%) had abnormal heart rate variability, 32.2% (30.6%, 33.8%) reported one or more severe hypoglycaemic attacks during the last 12 months and 8.6% (7.6%, 9.6%) reported hospital admission for ketosis over the same period. Microvascular and acute complications were clearly related to duration of diabetes and to glycaemic control. However, the relation of glycaemic control to raised albuminuria differed qualitatively from its relation to retinopathy.

PubMed Disclaimer

Comment in

• Autonomic neuropathy: comparison of two screening procedures.
  Kempler P, Kerényi Z, Tamás G. Kempler P, et al. Diabetologia. 1994 Nov;37(11):1168-9. doi: 10.1007/BF00418384. Diabetologia. 1994. PMID: 7867891 No abstract available.

Similar articles

• [Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"--results from the Vienna center].
  Abrahamian H, Hörnlein B, Gurdet C, Willinger C, Zaruba E, Irsigler K. Abrahamian H, et al. Wien Klin Wochenschr. 1994;106(5):136-40. Wien Klin Wochenschr. 1994. PMID: 8171869 German.
• Relation of fibre intake to HbA1c and the prevalence of severe ketoacidosis and severe hypoglycaemia. EURODIAB IDDM Complications Study Group.
  Buyken AE, Toeller M, Heitkamp G, Vitelli F, Stehle P, Scherbaum WA, Fuller JH. Buyken AE, et al. Diabetologia. 1998 Aug;41(8):882-90. doi: 10.1007/s001250051003. Diabetologia. 1998. PMID: 9726589
• Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
  Pettus JH, Zhou FL, Shepherd L, Preblick R, Hunt PR, Paranjape S, Miller KM, Edelman SV. Pettus JH, et al. Diabetes Care. 2019 Dec;42(12):2220-2227. doi: 10.2337/dc19-0830. Epub 2019 Sep 23. Diabetes Care. 2019. PMID: 31548241
• Glucose variability, HbA1c and microvascular complications.
  Škrha J, Šoupal J, Škrha J Jr, Prázný M. Škrha J, et al. Rev Endocr Metab Disord. 2016 Mar;17(1):103-10. doi: 10.1007/s11154-016-9347-2. Rev Endocr Metab Disord. 2016. PMID: 26975588 Review.

Cited by

• Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study.
  Soedamah-Muthu SS, Chaturvedi N, Fuller JH, Toeller M; EURODIAB Prospective Complications Study Group. Soedamah-Muthu SS, et al. Eur J Nutr. 2013 Oct;52(7):1701-10. doi: 10.1007/s00394-012-0473-7. Epub 2012 Dec 7. Eur J Nutr. 2013. PMID: 23224030
• Do Nutrients and Nutraceuticals Play a Role in Diabetic Retinopathy? A Systematic Review.
  Milluzzo A, Barchitta M, Maugeri A, Magnano San Lio R, Favara G, Mazzone MG, Sciacca L, Agodi A. Milluzzo A, et al. Nutrients. 2022 Oct 21;14(20):4430. doi: 10.3390/nu14204430. Nutrients. 2022. PMID: 36297113 Free PMC article. Review.
• Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study.
  Garofolo M, Lucchesi D, Giambalvo M, Aragona M, Bertolotto A, Campi F, Bianchi C, Francesconi P, Marchetti P, Del Prato S, Penno G. Garofolo M, et al. Cardiovasc Diabetol. 2024 Feb 28;23(1):85. doi: 10.1186/s12933-024-02171-9. Cardiovasc Diabetol. 2024. PMID: 38419065 Free PMC article.
• What the radiologist needs to know about the diabetic patient.
  Raptis AE, Markakis KP, Mazioti MC, Raptis SA, Dimitriadis GD. Raptis AE, et al. Insights Imaging. 2011 Apr;2(2):193-203. doi: 10.1007/s13244-011-0068-5. Epub 2011 Feb 2. Insights Imaging. 2011. PMID: 22347947 Free PMC article.
• [Comparison of risk factors and guideline oriented prevention and therapy of diabetic retinopathy between type 2 diabetes patients undergoing laser therapy and type 2 diabetes outpatients].
  Paschke R, Wuthe FG, Kühn K, Jochmann C, Wiedemann P. Paschke R, et al. Med Klin (Munich). 2010 Nov;105(11):772-8. doi: 10.1007/s00063-010-1131-6. Epub 2010 Dec 7. Med Klin (Munich). 2010. PMID: 21136234 German.

References

1. 1. Clin Chem. 1993 Apr;39(4):663-6 - PubMed
2. 1. J Pediatr. 1986 Apr;108(4):491-7 - PubMed
3. 1. Am J Med. 1991 Apr;90(4):450-9 - PubMed
4. 1. Invest Ophthalmol Vis Sci. 1981 Jul;21(1 Pt 2):1-226 - PubMed
5. 1. Br Med J (Clin Res Ed). 1985 Nov 9;291(6505):1330-2 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information